Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin's T-Cell Lymphoma

MLA

Fosmire, S., et al. “Inactivation of the P16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin’s T-Cell Lymphoma.” Veterinary Pathology, vol. 44, no. 4, July 2007, pp. 467–78. EBSCOhost, https://doi.org/10.1354/vp.44-4-467.

APA

Fosmire, S., Thomas, R., Jubala, C., Wojcieszyn, J., Valli, V., Getzy, D., Smith, T., Gardner, L., Ritt, M., Bell, J., Freeman, K., Greenfield, B., Lana, S., Kisseberth, W., Helfand, S., Cutter, G., Breen, M., & Modiano, J. (2007). Inactivation of the p16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin’s T-Cell Lymphoma. Veterinary Pathology, 44(4), 467–478. https://doi.org/10.1354/vp.44-4-467

Chicago

Fosmire, S., R. Thomas, C. Jubala, J. Wojcieszyn, V. Valli, D. Getzy, T. Smith, et al. 2007. “Inactivation of the P16 Cyclin-Dependent Kinase Inhibitor in High-Grade Canine Non-Hodgkin’s T-Cell Lymphoma.” Veterinary Pathology 44 (4): 467–78. doi:10.1354/vp.44-4-467.